Axomove, a France-based digital clinic platform for physical rehabilitation and prevention, has raised €4M in Series A funding led by Bpifrance's Fonds Prévention Numérique. The platform offers auto-reeducation via 1500+ expert video exercises, telereadaptation, teleconsultations, and medical telemonitoring. The capital will fuel commercial expansion, product enhancements like gamification, and extension to new indications such as obesity and arthrosis.
Bpifrance Prevention Fund Targets Tele-Rehab
The round marks the first investment from Bpifrance's new €100M Fonds Prévention Numérique, co-led by Go Capital with participation from Inco Ventures and Faraday Venture Partners. This comes amid a French HealthTech funding surge, with €86.5M across nine deals in one recent week. Sword Health, a global AI-driven MSK rival, has raised over $380M while entering the French market. Axomove's reimbursement by French social security for chronic low back pain sets it apart in Europe.
Chronic Back Pain Faces Reimbursement Barriers
Musculoskeletal disorders represent 87% of occupational diseases in France, driving high absenteeism costs. Current in-person rehab suffers from low adherence and post-hospital care gaps. Axomove addresses this with its ISO 13485 certified, CE-marked medical device, clinically validated for improved motivation and outcomes over paper-based programs.
Clinician Videos Boost Patient Adherence
Axomove Therapy delivers personalized programs from 1500+ evidence-based videos co-created by physiotherapists. Unlike fully automated AI coaches, it combines video exercises with live teleconsults and remote monitoring. Case studies show 55-82% pain reduction and €2430 ROI per user from clients like Allianz and Coca-Cola.
As Boris Lévêque, co-founder noted:
"La confiance d’investisseurs institutionnels de premier plan témoigne de la pertinence de notre stratégie et conforte notre ambition de devenir un standard de soin en matière de prévention et de rééducation."
Government Fund Signals Prevention Priority
Bpifrance's fund launch in February 2026 underscores France's push for digital prevention amid TMS epidemic. Prioritizing startups like Axomove aligns with national goals to relieve healthcare pressures. The investors provide strategic validation for scaling B2B to hospitals, insurers, and corporates, building on 150 clients reaching 750,000 people.
Telerehab Market Scales with Reimbursements
The telerehabilitation market stands at $6.97B in 2026, projected to reach $20.60B by 2034 at 14.5% CAGR per Fortune Business Insights. Digital MSK care grows from $4.4B in 2024 to $11.6B by 2030 at 17.7% CAGR according to Grand View Research. RecoveryOne, a U.S. virtual PT platform, raised $64M. Axomove leads locally with PECAN reimbursement, expanding beyond MSK.
Founders Blend Clinic and Product Expertise
Co-founders include Pierre-Yves Carlier, a specialized physiotherapist ensuring clinical rigor; Boris Leveque, ex-Decathlon product manager for MSK braces; Alexandre Morel, biotech PhD CTO; and CEO Clément Morel. This mix delivers a platform with strong evidence-based content and commercial traction, including partnerships with CHU Lille and Air France.
Obesity Studies Fuel Indication Expansion
Axomove plans to double its 30-person team in three years, integrate motion capture for engagement, and pursue reimbursements for obesity via the ON-TRAC clinical study. Deployments target enterprises for TMS prevention and international insurers like MSH for expats.